Evaluation of
rationally designed influenza vaccines

A collaborative effort by the ENDFLU consortium towards a next-generation influenza vaccine to protect citizens worldwide–an EU-India collaboration.

Who are we?

Find out more about the ENDFLU consortium.

Our activities

Learn how ENDFLU aims at maximizing the development and implementation of next-generation influenza vaccine candidates.

News and updates

The latest information about our work on next-generation influenza vaccines.

Contact us

Reach out to us for more information.

December 6, 2023
Obituary to Professor Gerd Sutter
It is with great sadness that we have learned about the death of our colleague and friend Gerd Sutter, at the age of 61 years. As the key initiator of...
Read More
July 6, 2022
Publications related to project ENDFLU
On 31 January 2022, the ENDFLU Consortium has provided the Periodic Communication Report to the European Union. The Consortium is proud to present the presentations related to ENDFLU from the...
Read More
September 3, 2020
ENDFLU virtual consortium kick-off
On 3 and 4 September 2020, the ENDFLU consortium officially started its activities by means of a virtual kick-off meeting.
Read More
April 1, 2020
EU awards contract to ENDFLU: an EU-India collaboration
The EU Research and Innovation programme HORIZON 2020 has awarded a contract to a consortium that aims towards a next generation influenza vaccine to protect citizens worldwide (an EU-India collaboration)....
Read More

The ENDFLU project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 874650.

See details

Evaluation of rationally designed influenza vaccines

Who are we?

Our activities

News and updates

Contact us

Obituary to Professor Gerd Sutter

Publications related to project ENDFLU

ENDFLU virtual consortium kick-off

EU awards contract to ENDFLU: an EU-India collaboration

Evaluation of
rationally designed influenza vaccines